A Dutch physician thought he was delivering the kind of death that euthanasia is meant to promise: planned, peaceful, and surrounded by family. Instead, his patient opened her eyes after the first coma-inducing injection and asked, "Is something else happening or what?" Four hours and four drug kits later, with paramedic assistance and injections into a groin vein and a neck artery, she died. 

For many readers responding to Medscape's February 2026 feature on euthanasia and assisted dying, the real shock was not just that the procedure failed. It was how little hard evidence underpins a process meant to be calm, controlled, and humane.

Some commenters focused on missing clinical rigor, asking why assisted death is not approached more like anesthesia, with better monitoring, clearer protocols, and more systematic reporting on complications. Others argued that the more urgent issue for patients facing intolerable suffering is not perfecting the technical aspects of the process but ensuring access to a lawful, humane death. Together, the comments sharpened the article's central question: What level of evidence, oversight, and transparency should patients be able to expect at the end of their lives?

More Like Anesthesia?

Several readers zeroed in on what they saw as an obvious gap: If the procedure depends on deep unconsciousness, why is it not managed more like an operation? 

One proposed bedside measurements of cerebral activity, noting that bispectral index monitoring is already used in operating rooms. The reader also asked, "Why not use it for a prospective cohort study to measure depth of sedation in euthanasia?" Another suggested bedside lung ultrasound to help determine whether pulmonary edema occurs in some patients.

Readers with anesthesia experience made a related point: Response to propofol and barbiturates can vary widely. One wrote that "there is a wide variation in the dose-response between individuals," arguing against overreliance on fixed protocols. Another said European protocols appeared to lack adequate input from anesthesiologists and asked why intravenous potassium chloride was not part of the discussion once unconsciousness had been achieved.

Their clinical point is that clinicians should know more about the behavior of very high doses of anesthetics, paralytics, and other potent drugs in frail patients and how to confirm deep unconsciousness.

For Some, the Issue Is Bigger

A smaller group of commenters rejected the premise that euthanasia should be refined as a medical procedure at all. Some framed the issue in religious terms, saying death should be left to God rather than physicians. Others argued more broadly that using prescription drugs to end life falls outside the proper scope of medicine, regardless of safeguards.

But several readers brought the discussion back to patient suffering. One asked bluntly whether critics had seen how peaceful dying can be for people with sepsis, cancer, or trauma. Another wrote, "The question isn't about pain," adding that what matters more is that people are free to choose euthanasia or assisted dying. Some argued that adults should be able to decide how life ends, even if the method is not perfectly studied.

That was one of the clearest fault lines in the discussion. For some readers, limited evidence and weak oversight were cause for alarm. For others, they were secondary to the suffering patients are trying to escape.

What Humane Death Requires

One of the thread's interesting themes was comparisons made with veterinary medicine. More than one reader suggested that veterinarians may have more practical experience with humane euthanasia than human medicine does. A small-animal veterinarian described a mg/kg-based sedation protocol followed by confirmation of an absent corneal reflex before administering pentobarbital, sometimes with propofol — a process refined over hundreds of cases.

If medicine is going to offer assisted death, other readers argued, it owes patients evidence that the process is as predictable and humane as possible. A legal framework alone is not enough. One commenter pointed to the US state of California, where systematic tracking includes recording time to unconsciousness, time to death, complications, and medications used.

Others were skeptical that certainty is achievable. But few seemed comfortable leaving the physiologic details as a black box. One commenter echoed a patient quoted in the Medscape feature, calling it "a final act of trust in a system that has repeatedly failed her."

Practical Suggestions 

Commenters offered several practical ways for improving how assisted dying is studied and carried out. These included:

• Adding objective monitoring of unconsciousness when feasible
• Collecting complication data prospectively rather than relying mainly on case reports and retrospective accounts
• Bringing anesthesiology expertise into protocol design, especially around drug choice, dosing variability, and airway effects
• Planning more explicitly for route-specific failures, including poor IV access, slow circulation, vomiting, and incomplete oral absorption
• Distinguishing between sedation, analgesia, and death when discussing what each drug is meant to do
• Keeping the patient's perspective in view when suffering is already severe and prolonged 

The comments did not resolve the debate but did sharpen its central tension. Many readers wanted assisted dying studied with the rigor of any other high-stakes intervention. Others remained unconvinced it belongs in medicine at all. What the thread made clear is that clinicians are not content to leave the hardest part to trust alone.